BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37604650)

  • 1. State of current management of the heightened risk for atherosclerotic cardiovascular events in an established cohort of patients with lupus erythematosus.
    Zhao M; Feng R; Werth VP; Williams KJ
    Lupus Sci Med; 2023 Aug; 10(2):. PubMed ID: 37604650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis.
    Keyes E; Grinnell M; Jacoby D; Vazquez T; Diaz D; Werth VP; Williams KJ
    Int J Womens Dermatol; 2021 Dec; 7(5Part A):560-575. PubMed ID: 35024413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study.
    Haugaard JH; Dreyer L; Ottosen MB; Gislason G; Kofoed K; Egeberg A
    J Am Acad Dermatol; 2021 Apr; 84(4):930-937. PubMed ID: 33321159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The differential panorama of clinical features of lupus erythematosus patients with different onset ages: a cross-sectional multicenter study from China.
    Yu Y; Jin H; Zhou S; Zhao M; Wu H; Long H; Fu S; Wu R; Yin H; Liao J; Luo S; Liu Y; Zhang Q; Zhang P; Tan Y; Huang X; Li F; Lin G; Lu Q
    Clin Rheumatol; 2023 Sep; 42(9):2353-2367. PubMed ID: 37311918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
    Hesselvig JH; Ahlehoff O; Dreyer L; Gislason G; Kofoed K
    Lupus; 2017 Jan; 26(1):48-53. PubMed ID: 27235406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
    Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
    Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term risk of adverse cardiovascular outcomes associated with cutaneous lupus erythematosus: a nationwide cohort study.
    Shams-Eldin AN; Yafasova A; Faurschou M; Schou M; Sun G; Gislason GH; Torp-Pedersen C; Fosbøl EL; Køber L; Butt JH
    Clin Rheumatol; 2022 Nov; 41(11):3525-3536. PubMed ID: 35907102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus.
    Zhu L; Singh M; Lele S; Sahakian L; Grossman J; Hahn B; McMahon M
    Lupus Sci Med; 2022 Feb; 9(1):. PubMed ID: 35193947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.
    Lu Q; Long H; Chow S; Hidayat S; Danarti R; Listiawan Y; Deng D; Guo Q; Fang H; Tao J; Zhao M; Xiang L; Che N; Li F; Zhao H; Lau CS; Ip FC; Ho KM; Paliza AC; Vicheth C; Godse K; Cho S; Seow CS; Miyachi Y; Khang TH; Ungpakorn R; Galadari H; Shah R; Yang K; Zhou Y; Selmi C; Sawalha AH; Zhang X; Chen Y; Lin CS
    J Autoimmun; 2021 Sep; 123():102707. PubMed ID: 34364171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: A Danish nationwide cohort study.
    Ahlehoff O; Wu JJ; Raunsø J; Kristensen SL; Khalid U; Kofoed K; Gislason G
    Lupus; 2017 Nov; 26(13):1435-1439. PubMed ID: 28618892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
    Grönhagen CM; Fored CM; Granath F; Nyberg F
    Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the progression from cutaneous lupus to systemic lupus erythematosus.
    Zhou W; Wu H; Zhao M; Lu Q
    Expert Rev Clin Immunol; 2020 Aug; 16(8):829-837. PubMed ID: 32746644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of clinical photosensitivity in cutaneous lupus erythematosus.
    Foering K; Chang AY; Piette EW; Cucchiara A; Okawa J; Werth VP
    J Am Acad Dermatol; 2013 Aug; 69(2):205-13. PubMed ID: 23648190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus.
    Urowitz MB; Gladman D; Ibañez D; Bae SC; Sanchez-Guerrero J; Gordon C; Clarke A; Bernatsky S; Fortin PR; Hanly JG; Wallace DJ; Isenberg D; Rahman A; Alarcón GS; Merrill JT; Ginzler E; Khamashta M; Nived O; Sturfelt G; Bruce IN; Steinsson K; Manzi S; Ramsey-Goldman R; Dooley MA; Zoma A; Kalunian K; Ramos M; Van Vollenhoven RF; Aranow C; Stoll T; Petri M; Maddison P;
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):881-7. PubMed ID: 20535799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines.
    Marston NA; Bonaca MP; Jarolim P; Goodrich EL; Bhatt DL; Steg PG; Cohen M; Storey RF; Johanson P; Wiviott SD; Braunwald E; Sabatine MS; Morrow DA
    JAMA Cardiol; 2020 Nov; 5(11):1255-1262. PubMed ID: 32756916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatologic Manifestations, Histologic Features and Disease Progression among Cutaneous Lupus Erythematosus Subtypes: A Prospective Observational Study in Asians.
    Chanprapaph K; Tankunakorn J; Suchonwanit P; Rutnin S
    Dermatol Ther (Heidelb); 2021 Feb; 11(1):131-147. PubMed ID: 33280074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous lupus erythematosus is associated with an increased risk of cardiac and vascular diseases: a large-scale, propensity-matched global retrospective cohort study.
    Olbrich H; Kridin K; Zirpel H; Sadik CD; Terheyden P; Thaçi D; Ludwig RJ; Boch K
    EBioMedicine; 2023 Jul; 93():104639. PubMed ID: 37285617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Risk of Autoimmune Diseases other than Systemic Lupus Erythematosus in Cutaneous Lupus Erythematosus-Alone Patients: A 10-Year Nationwide Cohort Study.
    Lin TL; Wu CY; Juan CK; Chang YT; Chen YJ
    Dermatology; 2022; 238(1):92-100. PubMed ID: 34062538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of depression in patients with cutaneous lupus erythematosus and systemic lupus erythematosus: a Danish nationwide cohort study.
    Hesselvig JH; Egeberg A; Kofoed K; Gislason G; Dreyer L
    Br J Dermatol; 2018 Nov; 179(5):1095-1101. PubMed ID: 29885269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
    Hageman SHJ; McKay AJ; Ueda P; Gunn LH; Jernberg T; Hagström E; Bhatt DL; Steg PG; Läll K; Mägi R; Gynnild MN; Ellekjær H; Saltvedt I; Tuñón J; Mahíllo I; Aceña Á; Kaminski K; Chlabicz M; Sawicka E; Tillman T; McEvoy JW; Di Angelantonio E; Graham I; De Bacquer D; Ray KK; Dorresteijn JAN; Visseren FLJ
    Eur Heart J; 2022 May; 43(18):1715-1727. PubMed ID: 35165703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.